Adult insulin dependent Americans will get a new cure, Afrezza insulin therapy, from the French manufacturer Sanofi and MannKind corporation. The licensing deal means that manufacturer will elaborate and put on sale Afrezza inhalated insulin therapy for diabetics.
Inhalated therapy can completely or partly replace the insuline injections and is a great scientific breakthrough in the battle against diabet. Affeza is planned to be launched in America at the begginning of 2015.
23:35 50 Cent $14.5 Mil from Lawyers He Accused Of Sleek Audio Screw Job6
03:00 Carrier incentives stir debate over 'rewarding' offshoring12
18:07 Trump’s deal to keep Carrier jobs in Indiana includes $7 million in state subsidies11
16:37 Wu-Tang Clan U-God Sues RZA and the Whole Clan For $2.5 MILLION!12